Sign in
4

Changes in Ownership

Voyager Therapeutics, Inc. Filed Acc 0001104659-24-005247

Chief Operating Officer sold 2,543 shares at $7.15 ($18,182)

From the SEC's structured data for this filing

Trades in this filing

Swartz Robin · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-17 Sale : show line 1 in the form −2,543 $7.15 $18,182 72,327 D
Open-market sales · 2,543 sh · avg $7.15 · $18,182
Loading xslF345X05/tm243664-2_4seq1.xml…